SKLB-015

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSKLB-015
Drug Alias NameSKLB-015
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSichuan University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSichuan UniversityCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A